These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36509338)

  • 1. Nutritional implications in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndrome.
    Guimarães VHD; Marinho BM; Motta-Santos D; Mendes GDRL; Santos SHS
    J Nutr Biochem; 2023 Mar; 113():109252. PubMed ID: 36509338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrition, the gut microbiome and the metabolic syndrome.
    Kovatcheva-Datchary P; Arora T
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):59-72. PubMed ID: 23768553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal symptoms, gut microbiome, probiotics and prebiotics in anorexia nervosa: A review of mechanistic rationale and clinical evidence.
    Dhopatkar N; Keeler JL; Mutwalli H; Whelan K; Treasure J; Himmerich H
    Psychoneuroendocrinology; 2023 Jan; 147():105959. PubMed ID: 36327759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome and metabolic syndrome.
    Mazidi M; Rezaie P; Kengne AP; Mobarhan MG; Ferns GA
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S150-7. PubMed ID: 26916014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
    Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
    Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbes: possible link between modern lifestyle transition and the rise of metabolic syndrome.
    Moossavi S; Bishehsari F
    Obes Rev; 2019 Mar; 20(3):407-419. PubMed ID: 30548384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and gut-microbiota-brain axis: A narrative review.
    Asadi A; Shadab Mehr N; Mohamadi MH; Shokri F; Heidary M; Sadeghifard N; Khoshnood S
    J Clin Lab Anal; 2022 May; 36(5):e24420. PubMed ID: 35421277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Gut Microbiota for Remediating Obesity and Related Metabolic Disorders.
    Wang B; Wang L; Wang H; Dai H; Lu X; Lee YK; Gu Z; Zhao J; Zhang H; Chen W; Wang G
    J Nutr; 2021 Jul; 151(7):1703-1716. PubMed ID: 33982127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective.
    Lin X; Han H; Wang N; Wang C; Qi M; Wang J; Liu G
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Probiotics intake as gut-microbiota modulating therapy in an interdisciplinary aspect].
    Szydłowska I; Marciniak A; Malanowska E; Nawrocka-Rutkowska J; Brodowska A
    Pol Merkur Lekarski; 2020 Aug; 49(286):279-281. PubMed ID: 32827426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE MICROBIOME AND METABOLIC DISORDERS: THE LINK BETWEEN THE GUT MICROBIOTA AND METABOLIC SYNDROME.
    Patel J D; Vikal A; Kumar V; Ahmad A; Sharma K; Asha K
    Georgian Med News; 2023; (340-341):153-158. PubMed ID: 37805890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
    De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
    Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of Gut Microbiota, Probiotics in Obesity: A Review.
    Pothuraju R; Sharma RK
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):212-220. PubMed ID: 29384067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Effects of Gut Microbiota on Metabolic Syndrome: A Patent Review.
    Singhal S; Rani V
    Recent Adv Food Nutr Agric; 2022 Nov; 13(1):17-26. PubMed ID: 35307002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and renin-angiotensin system: a complex interplay at local and systemic levels.
    Jaworska K; Koper M; Ufnal M
    Am J Physiol Gastrointest Liver Physiol; 2021 Oct; 321(4):G355-G366. PubMed ID: 34405730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.